Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Ecology ; 91(5): 1257-62, 2010 May.
Artigo em Inglês | MEDLINE | ID: mdl-20503858

RESUMO

Since the early 1990s, morbidity and mortality in tortoise populations have been associated with a transmissible, mycoplasmal upper respiratory tract disease (URTD). Although the etiology, transmission, and diagnosis of URTD have been extensively studied, little is known about the dynamics of disease transmission in free-ranging tortoise populations. To understand the transmission dynamics of Mycoplasma agassizii, the primary etiological agent of URTD in wild tortoise populations, we studied 11 populations of free-ranging gopher tortoises (Gopherus polyphemus; n = 1667 individuals) over five years and determined their exposure to the pathogen by serology, by clinical signs, and by detection of the pathogen in nasal lavages. Adults tortoises (n = 759) were 11 times more likely to be seropositive than immature animals (n = 242) (odds ratio = 10.6, 95% CI = 5.7-20, P < 0.0001). Nasal discharge was observed in only 1.4% (4/296) of immature tortoises as compared with 8.6% (120/1399) of adult tortoises. Nasal lavages from all juvenile tortoises (n = 283) were negative by PCR for mycoplasmal pathogens associated with URTD. We tested for spatial segregation among tortoise burrows by size class and found no consistent evidence of clustering of either juveniles or adults. We suggest that the social behavior of tortoises plays a critical role in the spread of URTD in wild populations, with immature tortoises having minimal interactions with adult tortoises, thereby limiting their exposure to the pathogen. These findings may have broader implications for modeling horizontally transmitted diseases in other species with limited parental care and emphasize the importance of incorporating animal behavior parameters into disease transmission studies to better characterize the host-pathogen dynamics.


Assuntos
Infecções por Mycoplasma/veterinária , Infecções Respiratórias/veterinária , Comportamento Social , Tartarugas , Animais , Conservação dos Recursos Naturais , Florida , Infecções por Mycoplasma/transmissão , Infecções Respiratórias/microbiologia , Infecções Respiratórias/transmissão
2.
J Zoo Wildl Med ; 37(2): 206-8, 2006 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17312804

RESUMO

Mycoplasma iguanae proposed species nova was isolated from vertebral abscesses of two feral iguanas (Iguana iguana) from Florida. Three strains were evaluated for sensitivity to a variety of antibiotics. The minimum inhibitory concentrations for M. iguanae, assessed by broth dilution methods, of clindamycin, doxycycline, enrofloxacin, oxytetracycline, and tylosin (all <1 microg/ml) were lower than those of chloramphenicol (32 micro/ml) and erythromycin (64 microg/ml). The profile was identical to that of Mycoplasma alligatoris, previously isolated from American alligators (Alligator mississippiensis). M. iguanae strain 2327T was subcultured without antibiotics to assess mycoplasmacidal activity. Clindamycin, doxycycline, oxytetracycline, and tylosin were bacteriostatic from 0.1 to 0.5 microg/ml, whereas enrofloxacin was bactericidal at 20 ng/ml. An enrofloxacin dosage of 5-10 mg/kg achieves peak plasma concentrations >1 microg/ml, with an elimination half-life of 6-20 hr, in alligators. Although concentrations achieved in the vertebrae by i.m. or i.v. injection are probably lower than those in plasma, these data suggest that enrofloxacin may be useful to treat M. iguanae mycoplasmosis in iguanas.


Assuntos
Antibacterianos/uso terapêutico , Fluoroquinolonas/uso terapêutico , Iguanas , Infecções por Mycoplasma/veterinária , Mycoplasma/efeitos dos fármacos , Abscesso/microbiologia , Animais , Antibacterianos/farmacocinética , Área Sob a Curva , Contagem de Colônia Microbiana/veterinária , Relação Dose-Resposta a Droga , Enrofloxacina , Evolução Fatal , Feminino , Fluoroquinolonas/farmacocinética , Meia-Vida , Iguanas/microbiologia , Testes de Sensibilidade Microbiana/veterinária , Infecções por Mycoplasma/tratamento farmacológico
3.
Vet Microbiol ; 157(1-2): 91-5, 2012 May 25.
Artigo em Inglês | MEDLINE | ID: mdl-22197303

RESUMO

Reannotation of the pathogenic Mycoplasma gallisepticum strain R(low) genome identified the hypothetical gene MGA_0329 as a homolog of the sialidase gene MS53_0199 of Mycoplasma synoviae strain MS53. Potent sialidase activity was subsequently quantitated in several M. gallisepticum strains. Because sialidase activity levels correlate significantly with differing M. synoviae strain virulence, we hypothesized this enzyme may also influence the virulence of M. gallisepticum. MGA_0329 was disrupted in strain R(low) to create mutants 6, 358 and P1C5, which resulted in the loss of sialidase activity in all three mutants. Chickens infected with the knockout mutants had significantly less severe (P<0.05) tracheal lesions and tracheal mucosal thickening than chickens infected with equal doses of strain R(low). Significantly fewer (P<0.05) CCU especially of strains 6 and P1C5 were recovered at necropsy. Mini-Tn4001tet plasmid pTF20 carrying a wild-type copy of MGA_0329 with its native promoter was used to complement the genetic lesion in strain P1C5. Three clones derived from P1C5, each having one copy of MGA_0329 stably transposed into a different site in its genome, expressed sialidase restored to wild-type activity levels (1.58×10(-8)U/CFU). Complementation of P1C5 with MGA_0329 did not restore it to wild-type levels of virulence, indicating that the contribution of sialidase to M. gallisepticum virulence is not straightforward.


Assuntos
Infecções por Mycoplasma/veterinária , Mycoplasma gallisepticum/enzimologia , Mycoplasma gallisepticum/patogenicidade , Neuraminidase/genética , Virulência , Animais , Galinhas/microbiologia , Técnicas de Inativação de Genes , Teste de Complementação Genética , Mutagênese Insercional , Infecções por Mycoplasma/microbiologia , Infecções por Mycoplasma/patologia , Mycoplasma gallisepticum/genética , Mycoplasma synoviae/enzimologia
4.
Clin Vaccine Immunol ; 14(9): 1190-5, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17626160

RESUMO

The precarious status of desert (Gopherus agassizii) and gopher (Gopherus polyphemus) tortoises has resulted in research and conservation efforts that include health assessments as a substantial component of management decision-making. Therefore, it is critical that available diagnostic tests for diseases impacting these species undergo rigorous standardization and validation. Since 1992, analysis of exposure of tortoises to Mycoplasma agassizii, an etiological agent of upper respiratory tract disease, has relied on the detection of specific M. agassizii antibody by enzyme-linked immunosorbent assay (ELISA). We report here substantive refinements in the diagnostic assay and discuss the implications of its use in wildlife conservation and management. The ELISA has been refined to include more stringent quality control measures and has been converted to a clinically more meaningful titer reporting system, consistent with other diagnostic serologic tests. The ELISA results for 5,954 desert and gopher tortoises were plotted, and a subset of these serum samples (n = 90) was used to determine end-point titers, to establish an optimum serum dilution for analyzing samples, and to construct a standard curve. The relationship between titer and A405 was validated using 77 serum samples from known positive (n = 48) and negative (n = 29) control tortoises from prior transmission studies. The Youden index, J, and the optimal cut point, c, were estimated using ELISA results from the 77 control sera. Based on this evaluation, the refinement has substantially improved the performance of the assay (sensitivity of 0.98, specificity of 0.99, and J of 0.98), thus providing a clinically more reliable diagnostic test for this important infection of tortoises.


Assuntos
Ensaio de Imunoadsorção Enzimática/métodos , Infecções por Mycoplasma/veterinária , Mycoplasma/isolamento & purificação , Tartarugas/sangue , Animais , Ensaio de Imunoadsorção Enzimática/normas , Mycoplasma/imunologia , Infecções por Mycoplasma/sangue , Infecções por Mycoplasma/imunologia , Infecções por Mycoplasma/microbiologia , Reprodutibilidade dos Testes , Sensibilidade e Especificidade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA